SCHEMBL28626188

SCHEMBL28626188

O=C(CCC(=O)ON1C(=O)CCC1=O)OC(=O)c1cccc(N2C(=O)C=CC2=O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.46
KMT2A Q03164 3/20 0.42
MGLL Q99685 6/20 0.40
FAAH O00519 3/20 0.40
MAPT P10636 2/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
HSP90AA1 P07900 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
GAA P10253 1/20 0.37
POLB P06746 1/20 0.37
NSD2 O96028 1/20 0.37
G6PD P11413 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29072378 0.88 MGLL (0.51) MAPK1KMT2AMGLLFAAHMAPT
SCHEMBL29354362 0.85 MAPK1 (0.54) MAPK1KMT2AMGLLFAAHMAPT
SCHEMBL79589 0.85 MAPK1 (0.54) MAPK1KMT2AMGLLFAAHMAPT
SCHEMBL28454818 0.85 NSD2 (0.45) MAPK1KMT2AMGLLFAAHMAPT
Succinic Acid SCHEMBL28454817 0.84 MAPK1 (0.51) MAPK1KMT2AMGLLFAAHMAPT
SCHEMBL29072379 0.83 MGLL (0.46) MAPK1KMT2AMGLLFAAHMAPT
SCHEMBL15991691 0.82 MAPK1 (0.46) MAPK1KMT2AMGLLFAAHMAPT
SCHEMBL11030538 0.78 KMT2A (0.53) MAPK1KMT2AMGLLFAAHMAPT
SCHEMBL8198691 0.78 MGLL (0.46) MAPK1KMT2AMGLLFAAHMAPT
SCHEMBL15337086 0.77 MGLL (0.47) MAPK1KMT2AMGLLFAAHMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113406320-B Directional coupling method based on recombinant gene engineering antibody and microsphere and application 南京立顶医疗科技有限公司 2021-11-02 CN disclosed
CN-113406320-A Directional coupling method based on recombinant gene engineering antibody and microsphere and application 南京立顶医疗科技有限公司 2021-09-17 CN disclosed